Produktname:3-Iodobenzylamine Hydrochloride

IUPAC Name:1-(3-iodophenyl)methanamine hydrochloride

CAS:3718-88-5
Molekulare Formel:C7H9ClIN
Reinheit:95%+
Katalognummer:CM117537
Molekulargewicht:269.51

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM117537-25g in stock Ɠůʼn

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:3718-88-5
Molekulare Formel:C7H9ClIN
Schmelzpunkt:-
SMILES-Code:NCC1=CC=CC(I)=C1.[H]Cl
Dichte:
Katalognummer:CM117537
Molekulargewicht:269.51
Siedepunkt:272.5°C at 760 mmHg
Mdl-Nr.:MFCD00012857
Lagerung:Keep in dark place, store at room temperature.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Nitrogen Compounds
Nitrogen compounds can be classified as mineral or organic. Mineral compounds are essentially formed by the ammonium ion (NH4+), which is generated when ammonium salts are dissolved in water. Organic compounds, in contrast, are carbon and hydrogen compounds that contain a nitrogen atom. All organic nitrogen-containing compounds can be considered as derivatives of ammonia in which one or more hydrogen atoms are substituted by hydrocarbon radicals.
Namodenoson
Namodenoson is a small orally bioavailable drug that binds with high affinity and selectivity to the A3 adenosine receptor (A3AR). Namodenoson was evaluated in Phase II trials for two indications, as a second line treatment for hepatocellular carcinoma, and as a treatment for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Namodenoson granted Orphan Drug and Fast track status from the FDA. A3AR is highly expressed in diseased cells whereas low expression is found in normal cells. This differential effect accounts for the excellent safety profile of the drug.

Related Products